Journal profile · Biochemistry, Genetics and Molecular Biology-Biotechnology
Biomedical and Biotechnology Research Journal
ISSN 2588-9834 · eISSN 2588-9842 · Wolters Kluwer Health · India
Biomedical and Biotechnology Research Journal: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1 (journal website); JCR Q4 (journal website); fully open access; APC about USD 200; median 91 days to acceptance (116 articles, last 24 months); 65 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Biomedical and Biotechnology Research Journal is published by Wolters Kluwer Health and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis and SARS-CoV-2 and COVID-19 Research, together about 29.6% of its articles. Its main subfields are Infectious Diseases and Epidemiology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Biotechnology
Editor-in-chief Parissa FarniaPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Tuberculosis Research and EpidemiologyMedicine12.7%
- Mycobacterium research and diagnosisMedicine8.9%
- SARS-CoV-2 and COVID-19 ResearchMedicine8%
- COVID-19 Clinical Research StudiesMedicine7.6%
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology6.3%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.3%
- Computational Drug Discovery MethodsComputer Science4.1%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q4 · BIOTECHNOLOGY & APPLIED MICROBIOLOGY · rank 170/180
- JCR Q4 · MEDICINE, RESEARCH & EXPERIMENTAL · rank 155/191
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1Publisher website ·
- CiteScore 2026-06
- 2.3LetPub ·
- SJR 2026-06
- 0.26LetPub ·
- SNIP 2026-06
- 0.45LetPub ·
- h-index
- 26OpenAlex ·
- i10-index
- 102OpenAlex ·
- 2-year mean citedness
- 1.41OpenAlex ·
- Self-citation rate
- 40%LetPub ·
- Share of gold OA articles
- 99.57%LetPub ·
Volume
- Articles per year
- 65LetPub ·
Articles by year OpenAlex count · 725 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 45 | 45 | 10 |
| 2025 | 65 | 65 | 64 |
| 2024 | 124 | 124 | 257 |
| 2023 | 93 | 93 | 322 |
| 2022 | 91 | 91 | 480 |
| 2021 | 74 | 74 | 552 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
91 daysMedian, submission to acceptance · P25–P75 82 days – 103 days
- Acceptance to online
- median 28 days (116 articles)
- Submission to online
- median 121 days
- Sample
- 116 articles with submission and acceptance dates (109 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 200 | No | CC BY-NC-SA | |
| LetPub | USD 200 | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- Country or region
- India
- Language
- English
- ISSN
- 2588-9834
- Electronic ISSN
- 2588-9842
- Latest issue on the website
- Volume 10, Issue 2 (June 2026)
- Official links
FAQ
Frequently asked questions about Biomedical and Biotechnology Research Journal
What CAS zone is Biomedical and Biotechnology Research Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, Biomedical and Biotechnology Research Journal is in Zone 4 of Medicine, and in Zone 4 of the minor category Biotechnology & Applied Microbiology / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Biomedical and Biotechnology Research Journal?
The journal's website gives an impact factor of 1; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.3, h-index 26.
How long does peer review take at Biomedical and Biotechnology Research Journal?
Based on the dates recorded on 116 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 82–103 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Biomedical and Biotechnology Research Journal in?
The journal's website gives JCR Q4; by category, BIOTECHNOLOGY & APPLIED MICROBIOLOGY Q4 (170/180), MEDICINE, RESEARCH & EXPERIMENTAL Q4 (155/191). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Biomedical and Biotechnology Research Journal?
According to LetPub and DOAJ records, Biomedical and Biotechnology Research Journal is indexed in ESCI, Scopus and DOAJ.
Is Biomedical and Biotechnology Research Journal open access, and what is the APC?
Biomedical and Biotechnology Research Journal is a fully open-access journal. APC about USD 200.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .